Cargando…
Capillary Leak Syndrome With Pulmonary Edema Preceded by Organizing Pneumonia Caused by Combination Therapy With Nivolumab and Ipilimumab: A Case Report
Treatment with drugs can cause lung disorders. Immune checkpoint inhibitors are often associated with organizing pneumonia. Capillary leak syndrome is a clinical form of drug-induced lung injury, a rare condition characterized by hemoconcentration, hypoalbuminemia, and hypovolemic shock. There have...
Autores principales: | Tachi, Hiroaki, Shibagaki, Atsuhito, Teshima, Shu, Hanazawa, Midori, Matsukura, Shihori, Shimizu, Kei, Yamamoto, Yusuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040893/ https://www.ncbi.nlm.nih.gov/pubmed/36994310 http://dx.doi.org/10.1016/j.jtocrr.2023.100491 |
Ejemplares similares
-
A case of COVID‐19 with superficial thrombophlebitis caused by an indwelling peripheral venous catheter
por: Tachi, Hiroaki, et al.
Publicado: (2021) -
Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
por: Chapman, Paul B, et al.
Publicado: (2021) -
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
por: Wolchok, Jedd D., et al.
Publicado: (2022) -
Reversible Myocardial Edema Secondary to Tagraxofusp-Induced Capillary Leak Syndrome
por: Mouhayar, Elie N., et al.
Publicado: (2021) -
Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
por: Potluri, Ravi, et al.
Publicado: (2019)